確定確度 86%Qualcomm's[1][3] release says it 'today announced its agreement to acquire Arduino[2]' alongside the 7 October 2025 'From Blink to Think' livestream; CNBC[4] reported the deal at 13:00 UTC on 7 October 2025.
Qualcomm agreed to acquire Arduino, the open-source electronics maker with more than 33 million active users, which keeps its brand and unveiled the UNO Q, its first 'dual-brain' board, on a Qualcomm Dragonwing chip.
China's market regulator opened an investigation into Qualcomm for completing its purchase of Israeli V2X chip designer Autotalks without notifying Beijing, after telling the regulator in 2024 it had dropped the deal.
92, Avenue des Champs-Élysées, Quartier du Faubourg-du-Roule, 8th Arrondissement of Paris, Paris, Ile-de-France, Metropolitan France, 75008, FranceAlo Yoga
Phillip Burton Federal Building & United States Courthouse, 450, Golden Gate Avenue, Civic Center, San Francisco, California, 94102, United StatesSalesforce
確定確度 87%アンタラ通信(2025年10月20日):プラボウォ大統領は「月曜日、ジャカルタの最高検察庁で、国の損失に対する代替金……13兆2,000億ルピアの引き渡しに立ち会った」('menyaksikan penyerahan uang pengganti kerugian negara ... sebesar Rp13,2 triliun di Kejaksaan Agung RI, Jakarta, Senin')。[1]
確定確度 83%All India Radio's report dated October 21, 2025 says "The Japanese Parliament has elected Takaichi Sanae as Japan's first female prime minister".[1]
Both houses of Japan's National Diet named LDP leader Sanae Takaichi prime minister on 21 October 2025, with 237 votes in the lower house and 125 in the upper house, making her the first woman to lead Japan.
ナイキは、ナイキ、ジョーダンブランド、コンバースのイノベーション、デザイン、製品の各チームをフィル・マッカートニー氏率いる単一のクリエーション組織に統合し、あわせてNike Mind、Project Amplify、Aero-FIT、Therma-FIT Air Milanoの各プラットフォームを発表した。
確定確度 87%Bayer's[1] release is stamped "24 October 2025 | 19:25 PM Europe/Amsterdam" and opens "Berlin, October 24, 2025 - Bayer announced today that the U.S. Food and Drug Administration (FDA[2]) has approved elinzanetant".
The FDA approves Bayer's Lynkuet (elinzanetant), the first drug to block both the NK1 and NK3 receptors, as a hormone-free treatment for moderate to severe hot flashes of menopause.